Crown Bioscience is a leading brand that aims to provide superior drug candidates to ensure patients receive the right treatment at the right time. They offer a wide range of products and services in the field of bioscience. Their services include Therapeutic Areas such as Oncology, where they offer in vitro services like 2D Cell Lines and Panels, PDX-Derived Cell Lines, and Organoids.

They also provide high content imaging services and a 3D Ex Vivo Patient Tissue Platform. In terms of in vivo services, Crown Bioscience offers Patient-Derived Xenograft Models, CDX Models, and Syngeneic Models, among others. They specialize in Immuno-oncology In Vitro Services and have developed Mi Xeno™ immune-mediated inflammatory disease models.

Crown Bioscience also offers various technologies such as Bioinformatics, Cell Line and Biosample Authentication, and RNA-Seq Panel Biomarker Analysis. Their expertise extends to clinical chemistry services, flow cytometry, digital pathology, and mass spectrometry-based proteomics. With their comprehensive range of products and services, Crown Bioscience is committed to advancing research and delivering innovative solutions in the field of bioscience